Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
66.38
+0.15 (0.23%)
Sep 5, 2025, 10:53 AM - Market open
Merus Revenue
Merus had revenue of $8.83M in the quarter ending June 30, 2025, with 20.40% growth. This brings the company's revenue in the last twelve months to $56.23M, up 59.77% year-over-year. In the year 2024, Merus had annual revenue of $36.13M, down -17.78%.
Revenue (ttm)
$56.23M
Revenue Growth
+59.77%
P/S Ratio
81.55
Revenue / Employee
$175,165
Employees
321
Market Cap
5.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 36.13M | -7.81M | -17.78% |
Dec 31, 2023 | 43.95M | 2.36M | 5.68% |
Dec 31, 2022 | 41.59M | -7.52M | -15.32% |
Dec 31, 2021 | 49.11M | 19.16M | 64.00% |
Dec 31, 2020 | 29.94M | -1.19M | -3.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
MRUS News
- 8 days ago - Merus to Present at the 2025 Wells Fargo Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Merus to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 4 weeks ago - Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Merus Global Investments Strengthens Leadership and Expands Talent Bench with Strategic Hires and Key Promotions - Business Wire
- 2 months ago - One of Finland's largest energy storage facilities commissioned in Lappeenranta – Merus Power's EUR 15 million delivery completed - GlobeNewsWire
- 3 months ago - Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus - Seeking Alpha
- 3 months ago - Merus N.V. Announces Pricing of Public Offering of Common Shares - GlobeNewsWire